Incidence of cardiometabolic and pulmonary events in UK has lowered due to COVID-19

NewsGuard 100/100 Score

Caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, coronavirus disease 2019 (COVID-19) is speculated to be involved in various pulmonary and cardiometabolic conditions. A team of researchers from the University of Oxford, the London School of Hygiene and Tropical Medicine and other institutions recently analyzed extensive data collected by NHS England to reveal any association between SARS-CoV-2 infection and cardiometabolic or respiratory events.

Interestingly, the group noted a drop in the incidence of such events in the non-COVID-19 population, but a high incidence of COVID-19 among patients with events. The team has recently released their findings on the medRxiv* preprint server.

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

How was the analysis performed?

NHS England has elected to publish extensive patient records for research and analysis in light of the pandemic on the OpenSAFELY server, which now contains records for over seventeen million adult patients. The group utilized this entire dataset and took into account information regarding death, the development of deep vein thrombosis, ischaemic stroke, pulmonary embolism, heart failure, myocardial infarction, diabetic ketoacidosis, or acute kidney injury for each month. The dataset was split into three categories: community patients with COVID-19, hospitalized patients with COVID-19, and those without COVID-19.

What were the results?

All of the above described cardiometabolic and pulmonary conditions and outcomes were noted to decrease since the start of the pandemic, except for death and ketoacidosis. Deaths were 73.4% higher in the month on April 2020 than the previous year, demonstrating the devastating effect of the SARS-CoV-2 virus. However, other outcomes lessened by between 5.9 and 40% in the total population.

In April 2020, 0.14% of the total population included in this study was hospitalized, which had risen to 0.18% by October 2020. Given this small percentage, it is clear that cardiometabolic and pulmonary events are massively overrepresented in COVID-19 patients, as up to a third of events occurred in the hospitalized COVID-19 population.

Not all of the hospitalized population will have been admitted due to COVID-19, and a patient may have obtained the infection at any point. Many patients may have acquired COVID-19 while in hospital due to the cardiometabolic and pulmonary events analyzed in this study. Alternatively, they may be attending hospital for another complaint, subsequently contract COVID-19, and then develop these events.

The available data did not allow the authors to fully ascertain the order of events, making distinguishing those with events resulting from COVID-19 hard to differentiate from those with events that then happen to have COVID-19, whether coincidentally or in association with compounding factors.

In support of the findings' accuracy, however, the authors point to a previously reported study that utilized hospital records and noted a 40% drop in the incidence of acute coronary syndromes during the early months of the pandemic. This work found only a 28.3% reduction in the same condition, though it included data from the community and not only those hospitalized.

What factors may have influenced the observation?

The authors suggest several possible scenarios that could explain the observed drop in the incidence of pulmonary and cardiometabolic events since the wide-spread emergence of COVID-19. These include reluctance to seek treatment during the pandemic and lessened exposure to risk factors such as air pollution or demanding physical activity.

They also note that competing risk of death is an important factor, as many of those that may have suffered from these events are also in the high-risk group for COVID-19. It is highly likely that a large portion of those that died with COVID-19 would have gone on to have one of the events investigated in this study at some point.

Further analysis of more detailed datasets covering specific portions of the population would allow researchers to better establish the order of events and whether any true causal relationship exists.

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:
Michael Greenwood

Written by

Michael Greenwood

Michael graduated from the University of Salford with a Ph.D. in Biochemistry in 2023, and has keen research interests towards nanotechnology and its application to biological systems. Michael has written on a wide range of science communication and news topics within the life sciences and related fields since 2019, and engages extensively with current developments in journal publications.  

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Greenwood, Michael. (2021, February 23). Incidence of cardiometabolic and pulmonary events in UK has lowered due to COVID-19. News-Medical. Retrieved on April 22, 2024 from https://www.news-medical.net/news/20210223/Incidence-of-cardiometabolic-and-pulmonary-events-in-UK-has-lowered-due-to-COVID-19.aspx.

  • MLA

    Greenwood, Michael. "Incidence of cardiometabolic and pulmonary events in UK has lowered due to COVID-19". News-Medical. 22 April 2024. <https://www.news-medical.net/news/20210223/Incidence-of-cardiometabolic-and-pulmonary-events-in-UK-has-lowered-due-to-COVID-19.aspx>.

  • Chicago

    Greenwood, Michael. "Incidence of cardiometabolic and pulmonary events in UK has lowered due to COVID-19". News-Medical. https://www.news-medical.net/news/20210223/Incidence-of-cardiometabolic-and-pulmonary-events-in-UK-has-lowered-due-to-COVID-19.aspx. (accessed April 22, 2024).

  • Harvard

    Greenwood, Michael. 2021. Incidence of cardiometabolic and pulmonary events in UK has lowered due to COVID-19. News-Medical, viewed 22 April 2024, https://www.news-medical.net/news/20210223/Incidence-of-cardiometabolic-and-pulmonary-events-in-UK-has-lowered-due-to-COVID-19.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses